ProcuraAxisBeta
Sign inCreate Free Account
Home / Opportunities / Opportunity
PROCUREMENT OPPORTUNITY

Aseptically Prepared Systemic Anti-Cancer Therapy Medicines

Mid South Essex NHS Foundation Trust · Tender notice on Find a Tender

Tender information last checkedLast checked 3 Oct 2026, 01:16.

Opportunity overview

This framework agreement is for the supply of a range of aseptically prepared, batch manufactured systemic anti-cancer therapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific systemic anti-cancer therapy drugs, CIVAs, and provisions for stock inventory management and supply of compounded systemic anti-cancer therapy.

Classification

  • CPV33600000 — Pharmaceutical products

Lots

  • Dose Banded Systemic Anti-Cancer Therapy Medicines£850m
  • Patient Specific Systemic Anti-Cancer Therapy Medicines£850m
  • CIVAS (Central Intravenous Additive Service)£850m
  • Stock Inventory Management and Supply of Compounded Systemic Anti-Cancer Therapy Medicines£850m

Documents and notices

Published notice details

Additional information from the published procurement release. Fields appear only when supplied by the source; check the original notice and tender documents before acting.

Scope, procedure and submissions

Id
PR-2264
Status
active
Procurement Method
open
Procurement Method Details
Open procedure
Main Procurement Category
goods
Above Threshold
Yes
How to submit
Via the Bravo Solutions Portal ONLY - https://healthtrusteurope.bravosolution.co.uk/web/login.shtml

Legal basis

Id
2023/54
Scheme
UKPGA

Participation Fees

Entry 1
Id
ocds-h6vhtk-051cde

Type

win

Relative Value

Proportion
0.02
Monetary Value
award

Techniques

Has Framework Agreement
Yes

Framework Agreement

Is Open Framework Scheme
Yes
Method
withAndWithoutReopeningCompetition
Type
closed
Description
Suppliers will be ranked based on their technical and commercial scores at award stage of this Framework. Call Off contracts will then be awarded via Direct Award or through further mini-competition with awarded suppliers under the applicable Lots. Specific technical and/or commercial elements will be awarded, scored and fed back on for all suppliers at framework award stage. Due to the nature of these goods and services, they may align to a customers requirements in these areas. These requirements and offerings will be differentiators at any call off stage, as well as any specific technical or commercial requirements presented by suppliers on the public sector landscape.
Open Framework Scheme End Date
30 Aug 2034, 23:59

Submission terms

Electronic Submission Policy
allowed

Languages

en

Tender Period

Ends
11 May 2026, 15:00

Enquiry period

Ends
1 May 2026, 17:00

Expected award period

Ends
23 Jun 2026, 23:59

Lot Details

Award criteria

Description
N/A

Lots and requirements

Entry 1
Id
1
Title
Dose Banded Systemic Anti-Cancer Therapy Medicines
Description
This Lot will cover the requirements for dose banded aseptically prepared systemic anti-cancer therapy medicines for adult and paediatric patients that can be supplied in batch or single units, and in line with National Dose Banded Tables where a specification exists.
Status
active

Value

Including VAT
850,000,000
Amount
850,000,000
Currency
GBP

Award criteria

Criteria

Criterion 1
Type
quality
Name
Technical (Including Social Value)

Numbers

Entry 1
Number
65
Weight
percentageExact
Criterion 2
Type
cost
Name
Cost

Numbers

Entry 1
Number
35
Weight
percentageExact

Selection criteria

Criteria

Criterion 1
Type
economic
Description
As per "ITT Guidance - Aseptically Prepared Systemic Anti-Cancer Therapy Medicines" and PSQ requirements.

Contract period

Starts
1 Sept 2026, 00:00
Ends
30 Aug 2034, 23:59
Entry 2
Id
2
Title
Patient Specific Systemic Anti-Cancer Therapy Medicines
Description
This Lot will cover the requirements for Patient Specific aseptically prepared anti-cancer therapy medicines in adult and paediatric patients.
Status
active

Value

Including VAT
850,000,000
Amount
850,000,000
Currency
GBP

Award criteria

Criteria

Criterion 1
Type
quality
Name
Technical (Including Social Value)

Numbers

Entry 1
Number
65
Weight
percentageExact
Criterion 2
Type
cost
Name
Cost

Numbers

Entry 1
Number
35
Weight
percentageExact

Selection criteria

Criteria

Criterion 1
Type
economic
Description
As per "ITT Guidance - Aseptically Prepared Systemic Anti-Cancer Therapy Medicines" and PSQ requirements.

Contract period

Starts
1 Sept 2026, 00:00
Ends
30 Aug 2034, 23:59
Entry 3
Id
3
Title
CIVAS (Central Intravenous Additive Service)
Description
This Lot covers the requirements for medicines used in CIVAs, and includes any preparation of medicine which is manipulated aseptically to create ready-to-use injectable medicine.
Status
active

Value

Including VAT
850,000,000
Amount
850,000,000
Currency
GBP

Award criteria

Criteria

Criterion 1
Type
quality
Name
Technical (Including Social Value)

Numbers

Entry 1
Number
65
Weight
percentageExact
Criterion 2
Type
cost
Name
Cost

Numbers

Entry 1
Number
35
Weight
percentageExact

Selection criteria

Criteria

Criterion 1
Type
economic
Description
As per "ITT Guidance - Aseptically Prepared Systemic Anti-Cancer Therapy Medicines" and PSQ requirements.

Contract period

Starts
1 Sept 2026, 00:00
Ends
30 Aug 2034, 23:59
Entry 4
Id
4
Title
Stock Inventory Management and Supply of Compounded Systemic Anti-Cancer Therapy Medicines
Description
This Lot covers the requirement for storage, warehousing, stock inventory management and stocking a range of batch systemic anti-cancer therapy medicines readily available for next-day or named day delivery.
Status
active

Value

Including VAT
850,000,000
Amount
850,000,000
Currency
GBP

Award criteria

Criteria

Criterion 1
Type
quality
Name
Technical (Including Social Value)

Numbers

Entry 1
Number
65
Weight
percentageExact
Criterion 2
Type
cost
Name
Cost

Numbers

Entry 1
Number
35
Weight
percentageExact

Selection criteria

Criteria

Criterion 1
Type
economic
Description
As per "ITT Guidance - Aseptically Prepared Systemic Anti-Cancer Therapy Medicines" and PSQ requirements.

Contract period

Starts
1 Sept 2026, 00:00
Ends
30 Aug 2034, 23:59

Items and delivery

Item 1
Id
1
Related Lot
1

Additional Classifications

Entry 1
Scheme
CPV
Id
33600000
Description
Pharmaceutical products

Delivery locations

Entry 1
Region
UKF
Country
GB
Country Name
United Kingdom
Entry 2
Region
UKG
Country
GB
Country Name
United Kingdom
Entry 3
Region
UKJ
Country
GB
Country Name
United Kingdom
Item 2
Id
2
Related Lot
2

Additional Classifications

Entry 1
Scheme
CPV
Id
33600000
Description
Pharmaceutical products

Delivery locations

Entry 1
Region
UKF
Country
GB
Country Name
United Kingdom
Entry 2
Region
UKG
Country
GB
Country Name
United Kingdom
Entry 3
Region
UKJ
Country
GB
Country Name
United Kingdom
Item 3
Id
3
Related Lot
3

Additional Classifications

Entry 1
Scheme
CPV
Id
33600000
Description
Pharmaceutical products

Delivery locations

Entry 1
Region
UKF
Country
GB
Country Name
United Kingdom
Entry 2
Region
UKG
Country
GB
Country Name
United Kingdom
Entry 3
Region
UKJ
Country
GB
Country Name
United Kingdom
Item 4
Id
4
Related Lot
4

Additional Classifications

Entry 1
Scheme
CPV
Id
33600000
Description
Pharmaceutical products

Delivery locations

Entry 1
Region
UKF
Country
GB
Country Name
United Kingdom
Entry 2
Region
UKG
Country
GB
Country Name
United Kingdom
Entry 3
Region
UKJ
Country
GB
Country Name
United Kingdom

Published documents

Entry 1
Id
conflictOfInterest
Document Type
conflictOfInterest
Description
Not published
Entry 2
Id
033144-2026
Document Type
tenderNotice
Notice Type
UK4
Description
Tender notice on Find a Tender
Published
13 Apr 2026, 10:48
Format
text/html

Buyer, suppliers and contacts

Organisation 1
Name
Mid South Essex NHS Foundation Trust
Id
GB-NHS-RAJ

Identifier

Scheme
GB-NHS
Id
RAJ

Address

Street Address
Nether Mayne
Locality
Basildon
Postal Code
SS16 5NL
Country
GB
Country Name
United Kingdom
Region
UKH37

Contact

Name
Customer Care
Telephone
01268 524900

Roles

buyer

Details

Classifications

Entry 1
Scheme
UK_CA_TYPE
Id
publicAuthorityCentralGovernment
Description
Public authority - central government
Organisation 2
Name
HealthTrust Europe LLP
Id
GB-COH-OC358224
Role Details
On 11th August 2021, Mid and South Essex NHS Foundation Trust (MSE) published a contract notice for procurement partner services. HealthTrust Europe LLP (HTE) was selected to provide these services under the MSE Framework, including access to HTE's public sector frameworks. HTE is now conducting this procurement exercise as part of its services to the Customers under the MSE Framework.

Identifier

Scheme
GB-COH
Id
OC358224

Address

Street Address
19 George Road
Locality
Birmingham
Postal Code
B15 1NU
Country
GB
Country Name
United Kingdom
Region
UKG31

Contact

Name
Customer Care
Telephone
08458875000

Roles

procuringEntity
processContactPoint

Details

Recorded locations

  • Buyer location · Basildon · UKH37 · SS16 5NL · United Kingdom
  • Delivery location · UKF · United Kingdom
  • Delivery location · UKG · United Kingdom
  • Delivery location · UKJ · United Kingdom

Notice and amendment history

1 published notice version reviewed by ProcuraAxis.

1 VERSION
  1. 033144-2026Tender notice on Find a Tender ·